263 related articles for article (PubMed ID: 17125205)
1. A cluster-based strategy for assessing the overlap between large chemical libraries and its application to a recent acquisition.
Engels MF; Gibbs AC; Jaeger EP; Verbinnen D; Lobanov VS; Agrafiotis DK
J Chem Inf Model; 2006; 46(6):2651-60. PubMed ID: 17125205
[TBL] [Abstract][Full Text] [Related]
2. NIPALSTREE: a new hierarchical clustering approach for large compound libraries and its application to virtual screening.
Böcker A; Schneider G; Teckentrup A
J Chem Inf Model; 2006; 46(6):2220-9. PubMed ID: 17125166
[TBL] [Abstract][Full Text] [Related]
3. Assessing the scaffold diversity of screening libraries.
Krier M; Bret G; Rognan D
J Chem Inf Model; 2006; 46(2):512-24. PubMed ID: 16562979
[TBL] [Abstract][Full Text] [Related]
4. Learning from the data: mining of large high-throughput screening databases.
Yan SF; King FJ; He Y; Caldwell JS; Zhou Y
J Chem Inf Model; 2006; 46(6):2381-95. PubMed ID: 17125181
[TBL] [Abstract][Full Text] [Related]
5. Applications of self-organizing neural networks in virtual screening and diversity selection.
Selzer P; Ertl P
J Chem Inf Model; 2006; 46(6):2319-23. PubMed ID: 17125175
[TBL] [Abstract][Full Text] [Related]
6. Novel 2D fingerprints for ligand-based virtual screening.
Ewing T; Baber JC; Feher M
J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
[TBL] [Abstract][Full Text] [Related]
7. A hierarchical clustering approach for large compound libraries.
Böcker A; Derksen S; Schmidt E; Teckentrup A; Schneider G
J Chem Inf Model; 2005; 45(4):807-15. PubMed ID: 16045274
[TBL] [Abstract][Full Text] [Related]
8. An efficient in silico screening method based on the protein-compound affinity matrix and its application to the design of a focused library for cytochrome P450 (CYP) ligands.
Fukunishi Y; Hojo S; Nakamura H
J Chem Inf Model; 2006; 46(6):2610-22. PubMed ID: 17125201
[TBL] [Abstract][Full Text] [Related]
9. A screening study of ChirBase molecular database to explore the expanded chiral pool derived from the application of chiral chromatography.
Piras P; Roussel C
J Pharm Biomed Anal; 2008 Apr; 46(5):839-47. PubMed ID: 17942261
[TBL] [Abstract][Full Text] [Related]
10. Basic overview of chemoinformatics.
Engel T
J Chem Inf Model; 2006; 46(6):2267-77. PubMed ID: 17125169
[TBL] [Abstract][Full Text] [Related]
11. Informative library design as an efficient strategy to identify and optimize leads: application to cyclin-dependent kinase 2 antagonists.
Bradley EK; Miller JL; Saiah E; Grootenhuis PD
J Med Chem; 2003 Sep; 46(20):4360-4. PubMed ID: 13678414
[TBL] [Abstract][Full Text] [Related]
12. Ligand-based approach to in silico pharmacology: nuclear receptor profiling.
Mestres J; Martín-Couce L; Gregori-Puigjané E; Cases M; Boyer S
J Chem Inf Model; 2006; 46(6):2725-36. PubMed ID: 17125212
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. A similarity-based data-fusion approach to the visual characterization and comparison of compound databases.
Medina-Franco JL; Maggiora GM; Giulianotti MA; Pinilla C; Houghten RA
Chem Biol Drug Des; 2007 Nov; 70(5):393-412. PubMed ID: 17927720
[TBL] [Abstract][Full Text] [Related]
15. Recent trends in library design: 'rational design' revisited.
Schnur DM
Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
[TBL] [Abstract][Full Text] [Related]
16. CLEVER: pipeline for designing in silico chemical libraries.
Song CM; Bernardo PH; Chai CL; Tong JC
J Mol Graph Model; 2009 Jan; 27(5):578-83. PubMed ID: 18986817
[TBL] [Abstract][Full Text] [Related]
17. Scaffold composition and biological relevance of screening libraries.
Shelat AA; Guy RK
Nat Chem Biol; 2007 Aug; 3(8):442-6. PubMed ID: 17637770
[TBL] [Abstract][Full Text] [Related]
18. Leadlikeness and structural diversity of synthetic screening libraries.
Verheij HJ
Mol Divers; 2006 Aug; 10(3):377-88. PubMed ID: 17031539
[TBL] [Abstract][Full Text] [Related]
19. "Bayes affinity fingerprints" improve retrieval rates in virtual screening and define orthogonal bioactivity space: when are multitarget drugs a feasible concept?
Bender A; Jenkins JL; Glick M; Deng Z; Nettles JH; Davies JW
J Chem Inf Model; 2006; 46(6):2445-56. PubMed ID: 17125186
[TBL] [Abstract][Full Text] [Related]
20. The impact of tautomer forms on pharmacophore-based virtual screening.
Oellien F; Cramer J; Beyer C; Ihlenfeldt WD; Selzer PM
J Chem Inf Model; 2006; 46(6):2342-54. PubMed ID: 17125178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
